- AstraZeneca shares drop 6% after company announces ‘routine’ safety pause in coronavirus vaccine trialCNBC
- Oxford vaccine trial on hold because of safety issueNBC News
- AstraZeneca halts Covid-19 vaccine trials to assess safety issuePOLITICO
- AstraZeneca vaccine trial paused to investigate ‘a potentially unexplained illness’ | TheHillThe Hill
- European shares end higher for first time in three sessionsReuters
- View Full Coverage on Google News